#KeiretsuBacked Virion Therapeutics advances its mission for a Hepatitis B Viral (HBV) functional cure, completing enrollment for the first two cohorts in its Phase 1b trial of VRON-0200. With a simple, well-tolerated immunotherapy approach, VRON-0200 shows promise as a potential treatment for chronic hepatitis B. Enrollment for Cohort 3 is now underway, bringing new hope to millions living with HBV. Learn more: https://lnkd.in/d9PhxaFM
Keiretsu Capital
风险投资与私募股权管理人
Seattle，WA 2,682 位关注者
Keiretsu Capital's mission is to create funds that leverage its unique network relationships. #FundingtheFuture
关于我们
Keiretsu Capital was established with the express mission of fostering closer ties between Keiretsu Forum angels, the institutional investor community and Keiretsu Forum portfolio companies. Keiretsu Capital provides its investors access to proprietary deal flow by investing alongside the angels, providing additional capital to complete rounds and acting to source follow on capital where appropriate. Keiretsu Capital works to increase the value of investments undertaken by Keiretsu Forum members by assisting in the successful presentation of the portfolio companies to investors including syndicate partners, venture capitalists, corporate investors, and the public markets. Keiretsu Capital aims to provide significant capital appreciation through investment in high quality emerging companies that have been funded by the world’s largest angel investor network, Keiretsu Forum, as well as other top tier angel groups. Comprised of serious investors, accomplished business leaders and serial entrepreneurs, our mission is to accelerate technology company success and pursue the high upside value potential in these dynamic investment opportunities while promoting the sharing of risk inherent in any early stage venture. We recognizes the crucial and active role that experienced angel investors can play in nurturing emerging companies, and draws upon the significant knowledge and expertise of our investors, Keiretsu Forum members and Keiretsu Capital managers to actively guide and support portfolio companies. We seek opportunities in which a strong management team is in place to guide development of the core technology and the organization needed to realize the company’s market potential. Further, we will continue to seek Keiretsu Members that bring geographic diversity to our membership to enhance the probability of identifying investment opportunities and building a broad base of contacts and functional and technical expertise. www.keiretsucapital.com
- 网站
-
https://www.keiretsucapital.com/
Keiretsu Capital的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- Seattle，WA
- 类型
- 合营企业
- 创立
- 2013
- 领域
- Angel Investment、Venture Capital、Co-Investment和Syndication
地点
-
主要
获取路线
2815 Eastlake Ave East
Suite 300
US，WA，Seattle，98102
Keiretsu Capital员工
动态
-
Get ready for a powerful day of innovation and investment as hundreds of active investors and top-tier companies across North America come together to spark new opportunities. Join us on Day Two of the Investor Capital Expo, in person or virtually via Zoom. Register now: https://lnkd.in/dXicSb3j
-
-
#KeiretsuBacked Vivia Cares brings its trusted home-care model to Olympia, offering flexible, personalized senior care with real-time family connectivity. With a dedicated team and a mobile app for seamless coordination, Vivia ensures seniors receive the support they need while giving families peace of mind. Learn more: https://lnkd.in/dAHzDDJh
-
-
Join some of the most powerful family offices on Day One of the Investor Capital Expo. We'll be discussing investment values, sharing thought leadership, and leveraging the Power Matching Exchange to strike partnerships. Book your seat now: https://lnkd.in/dT_peMJa
-
-
Drumrolls please! The sharpest investor minds and breakthrough companies will unite at the Investor Capital Expo on April 2nd and 3rd. Get ready for two days of exceptional deal flow, networking, and thought leadership. Register now for the biggest investment event of the year: https://lnkd.in/dMPk2_CB
-
#KeiretsuBacked Stracker Solar has been featured in the show Energy Horizons, aired Southern Oregon PBS (SOPBS). The coverage highlights Stracker Solar’s rise from an idea to an influential name in the commercial and industrial solar market. It also provides significant exposure to Stracker Solar and showcases their capabilities to the SOPBS audience. Learn more: https://lnkd.in/gJ2fdhrQ
-
-
Mark your calendars as the biggest congregation of the investor capital ecosystem arrives this April! Keiretsu Forum Northwest & Rockies’ Investor Capital Expo will bring together hundreds of investors and some of the most innovative companies for two days of deal flow, networking, and thought leadership. Book your place now: https://lnkd.in/dRGQjkak
-
-
#KeiretsuBacked b.well Connected Health is expanding into pharma and life sciences with a strategic investment from RTI International. The partnership integrates real-world patient data into research, streamlining drug development and post-launch support. With its digital infrastructure and interoperability, b.well is set to reshape the industry by enhancing patient-driven insights and accelerating research. Learn More: https://lnkd.in/dQXzhMdm
-
-
#KeiretsuBacked Inmedix Inc CEO Dr. Andrew J. Holman participated in the annual meeting of the Precision Medicine World Conference (PMWC2025) in Santa Clara, CA. He was alongside the top oncology, cardiovascular, and neurodegenerative diagnostics experts. He took the stage to share key insights on the role of stress biology and the autonomic nervous system in precision medicine. Learn more: https://lnkd.in/dNUviaD5
-
-
#KeiretsuBacked 20/20 GeneSystems is making strides in early cancer detection with OneTest? now available at 8 GIANT Pharmacies in Maryland! With training sessions completed and first samples arriving at the lab, the milestone positions 20/20 Gene Systems as a leader in making cancer detection more accessible and convenient. Learn more: https://lnkd.in/dj2M5YUx
-